Table 3.
Prognostic significance of inflammation parameters for the relapse-free survival of surgically resectable ovarian cancer.
| Variables | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | |
| Age (>55 vs.≤55) | 1.037 | 0.870-1.236 | 0.687 | |||
| Menopause (No vs. Yes) | 1.046 | 0.878-1.247 | 0.615 | |||
| FIGO stage | ||||||
| I | 0.084 | 0.034-0.207 | <0.001 | 0.116 | 0.046-0.290 | <0.001 |
| II | 0.217 | 0.131-0.359 | <0.001 | 0.273 | 0.161-0.461 | <0.001 |
| III | 0.787 | 0.631-0.981 | 0.033 | 0.812 | 0.649-1.016 | 0.069 |
| IV | 1.000 | 1.000 | ||||
| Family history of cancer (No vs. Yes) | 0.871 | 0.722-1.051 | 0.149 | |||
| Residual disease (>1cm vs. ≤1cm) | 1.599 | 1.257-2.035 | <0.001 | 1.349 | 1.058-1.720 | 0.016 |
| Histology (Other vs. Serous) | 0.473 | 0.356-0.630 | <0.001 | 0.647 | 0.484-0.865 | 0.003 |
| Grade | ||||||
| Well | 1.151 | 0.917-1.445 | 0.226 | |||
| Moderate | 1.202 | 0.962-1.502 | 0.106 | |||
| Poor | 1.000 | |||||
| Lymph node status (Negative vs. Positive) | 1.584 | 1.324-1.896 | <0.001 | 1.063 | 0.882-1.283 | 0.521 |
| CA125 at diagnosis (>35 U/ml vs.≤35 U/ml) | 0.949 | 0.629-1.430 | 0.801 | |||
| NLR (≥2.87 vs.<2.87) | 1.127 | 0.945-1.344 | 0.184 | |||
| LMR (≥3.39 vs.<3.39) | 0.685 | 0.568-0.827 | <0.001 | 0.810 | 0.661-0.992 | 0.042 |
| PLR (≥181.46 vs.<181.46) | 1.235 | 1.036-1.472 | 0.018 | 0.890 | 0.718-1.104 | 0.288 |
| SII (≥882.31 vs.<882.31) | 1.187 | 0.997-1.415 | 0.055 | |||
| PNR(≥49.20 vs.<49.20) | 1.402 | 1.177-1.670 | <0.001 | 1.351 | 1.103-1.656 | 0.004 |
The bold values represent P<0.05.